These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 24659124
1. Effects of imatinib mesylate in mouse models of multiple sclerosis and in vitro determinants. Azizi G, Haidari MR, Khorramizadeh M, Naddafi F, Sadria R, Javanbakht MH, Sedaghat R, Tofighi Zavareh F, Mirshafiey A. Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):198-206. PubMed ID: 24659124 [Abstract] [Full Text] [Related]
3. Imatinib mesylate: an innovation in treatment of autoimmune diseases. Azizi G, Mirshafiey A. Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):259-67. PubMed ID: 23947692 [Abstract] [Full Text] [Related]
4. Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis. Aminian A, Noorbakhsh F, Ghazi-Khansari M, Kafami L, Javadi S, Hassanzadeh G, Rahimian R, Dehpour AR, Mehr SE. Neuroscience; 2013 Sep 17; 248():299-306. PubMed ID: 23774631 [Abstract] [Full Text] [Related]
5. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O. Arthritis Rheum; 2007 Jan 17; 56(1):311-22. PubMed ID: 17195235 [Abstract] [Full Text] [Related]
6. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions. Pifarré P, Gutierrez-Mecinas M, Prado J, Usero L, Roura-Mir C, Giralt M, Hidalgo J, García A. Exp Neurol; 2014 Jan 17; 251():58-71. PubMed ID: 24211383 [Abstract] [Full Text] [Related]
10. In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice. Kandagaddala LD, Kang MJ, Haque MM, Im HY, Seo JE, Chung BC, Jung BH, Patterson TA, Kwon OS. J Neurol Sci; 2012 Jul 15; 318(1-2):36-44. PubMed ID: 22554692 [Abstract] [Full Text] [Related]
16. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Garay L, Gonzalez Deniselle MC, Gierman L, Meyer M, Lima A, Roig P, De Nicola AF. Neuroimmunomodulation; 2008 Jul 15; 15(1):76-83. PubMed ID: 18667803 [Abstract] [Full Text] [Related]
17. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE). Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS. J Neuroimmunol; 2008 Oct 15; 203(1):79-93. PubMed ID: 18687476 [Abstract] [Full Text] [Related]
18. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Zheng H, Zhang H, Liu F, Qi Y, Jiang H. Immunol Lett; 2014 Oct 15; 157(1-2):38-44. PubMed ID: 24220208 [Abstract] [Full Text] [Related]
19. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors. Kassis I, Petrou P, Halimi M, Karussis D. Immunol Lett; 2013 Oct 15; 154(1-2):70-6. PubMed ID: 23994102 [Abstract] [Full Text] [Related]